These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16225476)

  • 21. The combination of a high-fat diet and chronic stress aggravates insulin resistance in Wistar male rats.
    Fu JH; Xie SR; Kong SJ; Wang Y; Wei W; Shan Y; Luo YM
    Exp Clin Endocrinol Diabetes; 2009 Jul; 117(7):354-60. PubMed ID: 19358094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of nutritional status, body composition, inflammation and serum iron on the developement of insulin resistance among patients on long-term hemodialysis.
    Rasić-Milutinović Z; Perunicić G; Pljesa S; Gluvić Z; Ilić M; Stokić E
    Med Pregl; 2007; 60 Suppl 2():33-8. PubMed ID: 18928154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fatty acid regulation on visfatin gene expression in adipocytes.
    Wen Y; Wang HW; Wu J; Lu HL; Hu XF; Cianflone K
    Chin Med J (Engl); 2006 Oct; 119(20):1701-8. PubMed ID: 17097017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
    Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L
    AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.
    Moore GB; Pickavance LC; Briscoe CP; Clapham JC; Buckingham RE; Wilding JP
    Diabetes Obes Metab; 2008 Mar; 10(3):251-63. PubMed ID: 18269641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of iron metabolism disturbances in an animal model of insulin resistance.
    Le Guenno G; Chanséaume E; Ruivard M; Morio B; Mazur A
    Diabetes Res Clin Pract; 2007 Sep; 77(3):363-70. PubMed ID: 17350134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
    Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of three different conjugated linoleic acid preparations on insulin signalling, fat oxidation and mitochondrial function in rats fed a high-fat diet.
    Choi JS; Koh IU; Jung MH; Song J
    Br J Nutr; 2007 Aug; 98(2):264-75. PubMed ID: 17408517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of insulin resistance on adiponectin receptor expression in breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Maturitas; 2009 Jul; 63(3):253-6. PubMed ID: 19524379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour necrosis factor-alpha attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells.
    Pandey AK; Bhardwaj V; Datta M
    FEBS J; 2009 Jul; 276(14):3757-69. PubMed ID: 19769745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of regucalcin suppresses gene expression of insulin signaling-related proteins in cloned rat hepatoma H4-II-E cells: involvement of insulin resistance.
    Nakashima C; Yamaguchi M
    Int J Mol Med; 2007 Nov; 20(5):709-16. PubMed ID: 17912465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the transcription factor 7-like 2 gene (TCF7L2) in human adipocytes is down regulated by insulin.
    Ahlzén M; Johansson LE; Cervin C; Tornqvist H; Groop L; Ridderstråle M
    Biochem Biophys Res Commun; 2008 May; 370(1):49-52. PubMed ID: 18342627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance.
    Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
    Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex steroids enhance insulin receptors and glucose oxidation in Chang liver cells.
    Parthasarathy C; Renuka VN; Balasubramanian K
    Clin Chim Acta; 2009 Jan; 399(1-2):49-53. PubMed ID: 18834871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
    Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.